The global genetic testing market size was USD 13.01 Billion in 2022 and is expected to register a rapid revenue CAGR of 10.2% during the forecast period. Increasing prevalence of cancer and hereditary diseases, technological advancements, such as introduction of innovative new testing kits, rising focus on early disease detection and prevention, and decreasing cost of sequencing procedures are key factors driving market revenue growth.
The Genetic Testing Market report also offers details about market size, market share, revenue growth, and CAGR during the forecast period. The report also offers key insights about top companies in the market along with a thorough SWOT analysis, Porter’s Five Forces analysis, and feasibility analysis to offer competitive edge to the readers. The report focuses on the recent trends, major challenges and opportunities, and limitations pertaining to the ongoing pandemic.
The section on the competitive landscape offers valuable and actionable insights related to the business sphere of the Genetic Testing market, covering extensive profiling of the key market players. The report offers information about market share, product portfolio, pricing analysis, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, partnerships, product launches and brand promotions, among others. The report also discusses the initiatives taken by the key companies to combat the impact of the COVID-19 pandemic.
The leading market contenders listed in the report are:
Amgen Inc., F. Hoffmann-La Roche Ltd, Eurofins Scientific, Exact Sciences Corporation, Illumina, Inc., myriad genetics, Inc., Thermo Fisher Scientific Inc., Abbott, Ambry Genetics, Siemens Healthcare GmbH, Biocartis, Laboratory Corporation of America Holdings, and Natera, Inc
Emergen Research has segmented the global Genetic Testing market on the basis of type, application, end-use, and region:
Offerings Outlook (Revenue, USD Billion; 2019-2032)
Consumables & Reagents
Instruments
Services
Test Type Outlook (Revenue, USD Billion; 2019-2032)
Predictive and Presymptomatic Testing
Carrier Testing
Nutrigenomic Testing
Diagnostic Testing
Prenatal and New-born Testing
Others
Application Outlook (Revenue, USD Billion; 2019-2032)
Cancer Diagnosis
Genetic Disease
Cardiovascular Disease (CVD)
Others
The various regions analyzed in the report include:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Key Objectives of the Report:
Analysis and estimation of the Genetic Testing Market size and share for the projected period of 2022-2030
Extensive analysis of the key players of the market by SWOT analysis and Porter’s Five Forces analysis to impart a clear understanding of the competitive landscape
Study of current and emerging trends, restraints, drivers, opportunities, challenges, growth prospects, and risks of the global Genetic Testing Market
Analysis of the growth prospects for the stakeholders and investors through the study of the promising segments
Strategic recommendations to the established players and new entrants to capitalize on the emerging growth opportunities
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.